Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
As of 2026, retatrutide has not been approved by the MHRA, FDA, EMA, or any other regulatory authority for human or veterinary use
The study involved 338 adults with obesity (no diabetes) and compared weekly Retatrutide injections against placebo over 48 weeks
Its not about physical withdrawal, but rather about managing the underlying conditions effectively once youre no longer using the medication
These important gastrointestinal hormones play a key role in regulating important processes like glucose-dependent insulin secretion, suppression of glucagon secretion, delay in gastric emptying, etc
It is currently in Phase 3 clinical trials for weight loss in adults who are overweight, obese or have weight related health issues
